Anti-Human HLA-DRB Recombinant Antibody
-
产品编号
YR1018
-
别名
科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Apolizumab ( 阿泊珠单抗 ), Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab |
| Catalog Number | YR1018 |
| Molecular Name | Apolizumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 |
| Formulation | PBS, pH7.5 |
| Background | Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use. |
| CAS Number | 267227-08-7 |
| Application | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | HLA-DRB[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
